This inventor holds 2 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Boehringer Ingelheim International Gmbh. Active years: 2018-2025.
Company Filing History:
Years Active: 2018-2025
Title: Thomas Meinicke: Innovator in Pharmaceutical Compositions
Introduction
Thomas Meinicke is a notable inventor based in Mittelbiberach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of medical compositions. With a total of 2 patents to his name, Meinicke's work focuses on improving treatment options for patients with chronic kidney disease (CKD).
Latest Patents
Meinicke's latest patents include innovative uses of pharmaceutical combinations. One of his key inventions involves a specific DPP-4 inhibitor used in combination with metformin for CKD patients. This combination aims to enhance the therapeutic effects and improve patient outcomes.
Career Highlights
Meinicke is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role at the company allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
One of his notable coworkers is Maximilian Von Eynatten. Together, they work on advancing pharmaceutical innovations that can significantly impact patient care.
Conclusion
Thomas Meinicke's contributions to pharmaceutical inventions demonstrate his commitment to improving healthcare solutions. His innovative work continues to pave the way for advancements in medical treatments.